RAPT Therapeutics Overview
Valuation check: RAPT's PEG ratio is 646.11, above the Healthcare sector average of 11.64.
Get informed when a big investor buys or sells
+ Follow646.11
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for RAPT is 646.11. That is above the Healthcare sector average of 11.64. Investors often review this figure alongside RAPT Therapeutics's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, RAPT currently prints 646.11 for PEG ratio, while the sector average sits near 11.64. That is roughly 5450.3% above the sector mean. Large gaps often invite a closer look at RAPT Therapeutics's growth, margins, and balance sheet.
A PEG ratio of 646.11 for RAPT Therapeutics is not 'good' or 'bad' on its own. Compare it with the peer average (11.64) and with RAPT's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting RAPT's PEG ratio (646.11), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack RAPT Therapeutics's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
